Showing results (31-40 of 280) with videos related to
Sort By:
Pageof 28
Journal of the National Comprehensive Cancer Network : JNCCN|May 20, 2026
Real-World Representation in Prostate Cancer Clinical Trials: Needs and OpportunitiesHannah D McManus, Daniel J George, Jeffrey W ShevachClinical Medicine Insights. Oncology|November 16, 2011
Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?Rhonda L Bitting, Andrew J Armstrong, Daniel J GeorgeClinical Advances in Hematology & Oncology : H&O|February 25, 2012
New and emerging treatments for advanced prostate cancerDaniel J George, Philip W Kantoff, Daniel W LinBJU International|April 20, 2007
Anti-angiogenic therapy in renal cell cancerRamaprasad Srinivasan, Andrew J Armstrong, William Dahut, et al.Expert Opinion on Pharmacotherapy|December 24, 2014
Enzalutamide versus abiraterone acetate for the treatment of men with metastatic castration-resistant prostate cancerTian Zhang, Jason Zhu, Daniel J George, et al.Urologic Oncology|August 9, 2016
Metastatic clear cell renal cell carcinoma: Circulating biomarkers to guide antiangiogenic and immune therapiesTian Zhang, Jason Zhu, Daniel J George, et al.Asian Journal of Urology|December 22, 2017
Novel immunotherapy approaches for metastatic urothelial and renal cell carcinomaZhiying Shao, Andrew Z Wang, Daniel J George, et al.Future Oncology (London, England)|November 16, 2016
Cabozantinib in genitourinary malignanciesTian Zhang, Se Eun Park, Cierra Hong, et al.Precision Clinical Medicine|January 29, 2019
The promise of immunotherapy in genitourinary malignanciesTian Zhang, Andrew J Armstrong, Daniel J George, et al.Cancer Treatment and Research Communications|June 22, 2020
The landscape of contemporary clinical trials for untreated metastatic clear cell renal cell carcinomaTian Zhang, Joyce K Hwang, Daniel J George, et al.Pageof 28